CIK 0001472091
- Non-accelerated filer
- Smaller reporting company
PDS Biotechnology Corp
Sign in to watch- Ticker
- PDSB
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 264231384
- Phone
- +1 800-208-3343
- Business address
- 303A COLLEGE ROAD EAST, PRINCETON, NJ, 08540
- Former names
- Edge Therapeutics, Inc.
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 4 Option exercise Director acquired 10,000 shares (option exercise)
- 4 Option exercise Director acquired 10,000 shares (option exercise)
- 4 Option exercise Chief Financial Officer acquired 82,999 shares (option exercise)
- 4 Option exercise Director acquired 10,000 shares (option exercise)
- 4 Option exercise Senior VP, GC and Secretary acquired 49,766 shares (option exercise)
- 4 Option exercise Director acquired 10,000 shares (option exercise)
- 4 Option exercise President and CEO acquired 169,032 shares (option exercise)
- 4 Option exercise Director acquired 10,000 shares (option exercise)
- 4 Option exercise Director acquired 10,000 shares (option exercise)
- 4 Option exercise Director acquired 10,000 shares (option exercise)
- 4 Option exercise Director acquired 20,000 shares (option exercise)
- 4/A Insider Changes in Ownership
- 4/A Insider Changes in Ownership
- 4/A Insider Changes in Ownership
- 4/A Insider Changes in Ownership
- 4/A Insider Changes in Ownership
Page 7 of 14 · 272 filings